| Name | AD57 |
|---|---|
| Synonyms |
1-[4-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)phenyl]-3-[3-(trifluoromethyl)phenyl]urea
Urea, N-[4-[4-amino-1-(1-Methylethyl)-1H-pyrazolo[3,4-d]pyriMidin-3-yl]phenyl]-N'-[3-(trifluoroMethyl)phenyl] AD57, 10 mM in DMSO 1-{4-[4-amino-1-(1-methylethyl)-1h-pyrazolo[3,4-d]pyrimidin-3-yl]phenyl}-3-[3-(trifluoromethyl)phenyl]urea |
| Description | AD57 is an orally active multikinase inhibitor, inhibits RET, BRAF, S6K and Src, with greatly reduces mTOR activity[1]. |
|---|---|
| Related Catalog | |
| Target |
Braf |
| In Vitro | AD57 (0.2 nM) 显著抑制了 ptc > dRetMEN2B 在果蝇幼虫中的致死率[1]。 AD57 (0.1 nM) 通过减少 erk 基因剂量提高 ptc > dRetMEN2B 在果蝇中的存活率[1]。 |
| In Vivo | AD57 抑制 RETMEN2 模型中 MEN2B (MZ-CRC-1) 和 MEN2A (TT) 患者来源细胞系的生存能力[1]。 AD57 (20 mg/kg) 在常规小鼠异种移植模型中显著抑制 TT 基肿瘤生长,无明显细胞毒性[1]。 |
| References |
| Molecular Formula | C22H20F3N7O |
|---|---|
| Molecular Weight | 455.44 |